Clinical Trials Browser

Phase 2 × NETWORK × Theophylline × Clear all

NCT00003808 2023-06-22

Theophylline in Treating Patients With In Situ, Stage I, or Stage II Chronic Lymphocytic Leukemia

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell